메뉴 건너뛰기




Volumn 66, Issue 2, 2017, Pages 379-388

Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; RITUXIMAB; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; ENTECAVIR; GUANINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

EID: 85021228368     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.29082     Document Type: Article
Times cited : (141)

References (44)
  • 1
    • 84922953411 scopus 로고    scopus 로고
    • American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy
    • quiz e216–e217
    • Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 2015;148:215-219; quiz e216–e217.
    • (2015) Gastroenterology , vol.148 , pp. 215-219
    • Reddy, K.R.1    Beavers, K.L.2    Hammond, S.P.3    Lim, J.K.4    Falck-Ytter, Y.T.5
  • 2
    • 84922858375 scopus 로고    scopus 로고
    • American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy
    • Perrillo RP, Gish R, Falck-Ytter YT. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 2015;148:221-244.
    • (2015) Gastroenterology , vol.148 , pp. 221-244
    • Perrillo, R.P.1    Gish, R.2    Falck-Ytter, Y.T.3
  • 3
    • 84921475521 scopus 로고    scopus 로고
    • Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?
    • Di Bisceglie AM, Lok AS, Martin P, Terrault N, Perrillo RP, Hoofnagle JH. Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg? Hepatology 2015;61:703-711.
    • (2015) Hepatology , vol.61 , pp. 703-711
    • Di Bisceglie, A.M.1    Lok, A.S.2    Martin, P.3    Terrault, N.4    Perrillo, R.P.5    Hoofnagle, J.H.6
  • 4
    • 84928734783 scopus 로고    scopus 로고
    • Preventing hepatitis B reactivation due to immunosuppressive drug treatments
    • Perrillo RP, Martin P, Lok AS. Preventing hepatitis B reactivation due to immunosuppressive drug treatments. JAMA 2015;313:1617-1618.
    • (2015) JAMA , vol.313 , pp. 1617-1618
    • Perrillo, R.P.1    Martin, P.2    Lok, A.S.3
  • 5
    • 70349240414 scopus 로고    scopus 로고
    • Chronic hepatitis B: update 2009
    • Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-662.
    • (2009) Hepatology , vol.50 , pp. 661-662
    • Lok, A.S.1    McMahon, B.J.2
  • 6
    • 84878870175 scopus 로고    scopus 로고
    • Immunosuppression and HBV reactivation
    • Shouval D, Shibolet O. Immunosuppression and HBV reactivation. Semin Liver Dis 2013;33:167-177.
    • (2013) Semin Liver Dis , vol.33 , pp. 167-177
    • Shouval, D.1    Shibolet, O.2
  • 8
    • 84941190611 scopus 로고    scopus 로고
    • Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis
    • Mozessohn L, Chan KK, Feld JJ, Hicks LK. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis. J Viral Hepat 2015;22:842-849.
    • (2015) J Viral Hepat , vol.22 , pp. 842-849
    • Mozessohn, L.1    Chan, K.K.2    Feld, J.J.3    Hicks, L.K.4
  • 9
    • 78349278037 scopus 로고    scopus 로고
    • Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma
    • Matsue K, Kimura S, Takanashi Y, Iwama K, Fujiwara H, Yamakura M, et al. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma. Cancer 2010;116:4769-4776.
    • (2010) Cancer , vol.116 , pp. 4769-4776
    • Matsue, K.1    Kimura, S.2    Takanashi, Y.3    Iwama, K.4    Fujiwara, H.5    Yamakura, M.6
  • 10
    • 59149085061 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab
    • Yeo W, Chan TC, Leung NWY, Lam WY, Mo FKF, Miu TC, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009;27:605-611.
    • (2009) J Clin Oncol , vol.27 , pp. 605-611
    • Yeo, W.1    Chan, T.C.2    Leung, N.W.Y.3    Lam, W.Y.4    Mo, F.K.F.5    Miu, T.C.6
  • 11
    • 80055100653 scopus 로고    scopus 로고
    • Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
    • Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, et al. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis. Ann Hematol 2011;90:1219-1223.
    • (2011) Ann Hematol , vol.90 , pp. 1219-1223
    • Koo, Y.X.1    Tay, M.2    Teh, Y.E.3    Teng, D.4    Tan, D.S.5    Tan, I.B.6
  • 12
    • 44949169340 scopus 로고    scopus 로고
    • Hepatitis B virus–related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy
    • Targhetta C, Cabras MG, Mamusa AM, Mascia G, Angelucci E. Hepatitis B virus–related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy. Haematologica 2008;93:951-952.
    • (2008) Haematologica , vol.93 , pp. 951-952
    • Targhetta, C.1    Cabras, M.G.2    Mamusa, A.M.3    Mascia, G.4    Angelucci, E.5
  • 13
    • 0034685429 scopus 로고    scopus 로고
    • Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group
    • Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
    • (2000) JAMA , vol.283 , pp. 2008-2012
    • Stroup, D.F.1    Berlin, J.A.2    Morton, S.C.3    Olkin, I.4    Williamson, G.D.5    Rennie, D.6
  • 15
    • 64549090671 scopus 로고    scopus 로고
    • Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells
    • Rucker G, Schwarzer G, Carpenter J, Olkin I. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Stat Med 2009;28:721-738.
    • (2009) Stat Med , vol.28 , pp. 721-738
    • Rucker, G.1    Schwarzer, G.2    Carpenter, J.3    Olkin, I.4
  • 16
    • 85100415918 scopus 로고    scopus 로고
    • eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration; 2011. Accessed at, Accessed August 15, 2016
    • Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration; 2011. Accessed at www.cochrane-handbook.org. Accessed August 15, 2016.
    • Higgins, J.P.T.1    Green, S.2
  • 17
    • 33748090675 scopus 로고    scopus 로고
    • A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints
    • Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006;25:3443-3457.
    • (2006) Stat Med , vol.25 , pp. 3443-3457
    • Harbord, R.M.1    Egger, M.2    Sterne, J.A.3
  • 19
    • 77958110812 scopus 로고    scopus 로고
    • Conducting meta-analyses in R with the metafor package
    • Accessed July 20, 2016
    • Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010;36:1-48. http://www.jstatsoft.org/v36/i03/. Accessed July 20, 2016.
    • (2010) J Stat Softw , vol.36 , pp. 1-48
    • Viechtbauer, W.1
  • 20
    • 84922621137 scopus 로고    scopus 로고
    • Prospective study of hepatitis B virus reactivation in patients with hematological malignancies
    • Pompili M, Basso M, Hohaus S, Bosco G, Nosotti L, D'Andrea M, et al. Prospective study of hepatitis B virus reactivation in patients with hematological malignancies. Ann Hepatol 2015;14:168-174.
    • (2015) Ann Hepatol , vol.14 , pp. 168-174
    • Pompili, M.1    Basso, M.2    Hohaus, S.3    Bosco, G.4    Nosotti, L.5    D'Andrea, M.6
  • 21
    • 84942038524 scopus 로고    scopus 로고
    • Monitoring of hepatitis B virus (HBV) DNA and risk of HBV reactivation in B-cell lymphoma: a prospective observational study
    • Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Takasaki H, et al. Monitoring of hepatitis B virus (HBV) DNA and risk of HBV reactivation in B-cell lymphoma: a prospective observational study. Clin Infect Dis 2015;61:719-729.
    • (2015) Clin Infect Dis , vol.61 , pp. 719-729
    • Kusumoto, S.1    Tanaka, Y.2    Suzuki, R.3    Watanabe, T.4    Nakata, M.5    Takasaki, H.6
  • 22
    • 84911424291 scopus 로고    scopus 로고
    • Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study
    • Seto WK, Chan TSY, Hwang YY, Wong DKH, Fung J, Liu KSH, et al. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study. J Clin Oncol 2014;32:3736-3743.
    • (2014) J Clin Oncol , vol.32 , pp. 3736-3743
    • Seto, W.K.1    Chan, T.S.Y.2    Hwang, Y.Y.3    Wong, D.K.H.4    Fung, J.5    Liu, K.S.H.6
  • 23
    • 84929095965 scopus 로고    scopus 로고
    • The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy
    • Lu S, Xu Y, Mu Q, Cao L, Chen J, Zhu Z, et al. The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy. Leuk Lymphoma 2015;56:1027-1032.
    • (2015) Leuk Lymphoma , vol.56 , pp. 1027-1032
    • Lu, S.1    Xu, Y.2    Mu, Q.3    Cao, L.4    Chen, J.5    Zhu, Z.6
  • 24
    • 84883051828 scopus 로고    scopus 로고
    • Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma
    • Matsui T, Kang J-H, Nojima M, Tomonari A, Aoki H, Yamazaki H, et al. Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma. J Med Virol 2013;85:1900-1906.
    • (2013) J Med Virol , vol.85 , pp. 1900-1906
    • Matsui, T.1    Kang, J.-H.2    Nojima, M.3    Tomonari, A.4    Aoki, H.5    Yamazaki, H.6
  • 25
    • 84901591515 scopus 로고    scopus 로고
    • Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study
    • Hsu C, Tsou HH, Lin SJ, Wang MC, Yao M, Hwang WL, et al. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology 2014;59:2092-2100.
    • (2014) Hepatology , vol.59 , pp. 2092-2100
    • Hsu, C.1    Tsou, H.H.2    Lin, S.J.3    Wang, M.C.4    Yao, M.5    Hwang, W.L.6
  • 26
    • 77549084321 scopus 로고    scopus 로고
    • Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy
    • Francisci D, Falcinelli F, Schiaroli E, Capponi M, Belfiori B, Flenghi L, et al. Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy. Infection 2010;38:58-61.
    • (2010) Infection , vol.38 , pp. 58-61
    • Francisci, D.1    Falcinelli, F.2    Schiaroli, E.3    Capponi, M.4    Belfiori, B.5    Flenghi, L.6
  • 27
    • 10744225593 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations
    • Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, et al. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. Haematologica 2003;88:1296-1303.
    • (2003) Haematologica , vol.88 , pp. 1296-1303
    • Picardi, M.1    Pane, F.2    Quintarelli, C.3    De Renzo, A.4    Del Giudice, A.5    De Divitiis, B.6
  • 28
    • 0026088152 scopus 로고
    • Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study
    • Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991;100:182-188.
    • (1991) Gastroenterology , vol.100 , pp. 182-188
    • Lok, A.S.1    Liang, R.H.2    Chiu, E.K.3    Wong, K.L.4    Chan, T.K.5    Todd, D.6
  • 29
    • 33745753570 scopus 로고    scopus 로고
    • Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy
    • Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006;131:59-68.
    • (2006) Gastroenterology , vol.131 , pp. 59-68
    • Hui, C.K.1    Cheung, W.W.2    Zhang, H.Y.3    Au, W.Y.4    Yueng, Y.H.5    Leung, A.Y.6
  • 30
    • 84939937110 scopus 로고    scopus 로고
    • Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy
    • Totani H, Kusumoto S, Ishida T, Masuda A, Yoshida T, Ito A, et al. Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy. Int J Hematol 2015;101:398-404.
    • (2015) Int J Hematol , vol.101 , pp. 398-404
    • Totani, H.1    Kusumoto, S.2    Ishida, T.3    Masuda, A.4    Yoshida, T.5    Ito, A.6
  • 31
    • 84945436648 scopus 로고    scopus 로고
    • Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy
    • Lee JY, Lim SH, Lee MY, Kim H, Sinn DH, Gwak GY, et al. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver Int 2015;35:2363-2369.
    • (2015) Liver Int , vol.35 , pp. 2363-2369
    • Lee, J.Y.1    Lim, S.H.2    Lee, M.Y.3    Kim, H.4    Sinn, D.H.5    Gwak, G.Y.6
  • 32
    • 84935843497 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
    • Chen KL, Chen J, Rao HL, Guo Y, Huang HQ, Zhang L, et al. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival. Chin J Cancer 2015;34:225-234.
    • (2015) Chin J Cancer , vol.34 , pp. 225-234
    • Chen, K.L.1    Chen, J.2    Rao, H.L.3    Guo, Y.4    Huang, H.Q.5    Zhang, L.6
  • 33
    • 84929328069 scopus 로고    scopus 로고
    • High risk of hepatitis B reactivation among patients with acute myeloid leukemia
    • Chen CY, Huang SY, Cheng A, Chou WC, Yao M, Tang JL, et al. High risk of hepatitis B reactivation among patients with acute myeloid leukemia. PLoS One 2015;10:e0126037.
    • (2015) PLoS One , vol.10
    • Chen, C.Y.1    Huang, S.Y.2    Cheng, A.3    Chou, W.C.4    Yao, M.5    Tang, J.L.6
  • 34
    • 83155165301 scopus 로고    scopus 로고
    • Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy
    • Cheung WI, Lin SY, Leung VK, Fung KS, Lam YK, Lo FH, et al. Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy. Hong Kong Med J 2011;17:376-380.
    • (2011) Hong Kong Med J , vol.17 , pp. 376-380
    • Cheung, W.I.1    Lin, S.Y.2    Leung, V.K.3    Fung, K.S.4    Lam, Y.K.5    Lo, F.H.6
  • 35
    • 74549162133 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy
    • Koo YX, Tan DS, Tan IB, Tao M, Chow WC, Lim ST. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy. Cancer 2010;116:115-121.
    • (2010) Cancer , vol.116 , pp. 115-121
    • Koo, Y.X.1    Tan, D.S.2    Tan, I.B.3    Tao, M.4    Chow, W.C.5    Lim, S.T.6
  • 36
    • 77955784928 scopus 로고    scopus 로고
    • Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/HBcAb-positive: a multicenter retrospective study
    • Ji D, Cao J, Hong X, Li J, Wang J, Chen F, et al. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/HBcAb-positive: a multicenter retrospective study. Eur J Haematol 2010;85:243-250.
    • (2010) Eur J Haematol , vol.85 , pp. 243-250
    • Ji, D.1    Cao, J.2    Hong, X.3    Li, J.4    Wang, J.5    Chen, F.6
  • 37
    • 84884755581 scopus 로고    scopus 로고
    • Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B
    • Huang YH, Hsiao LT, Hong YC, Chiou TJ, Yu YB, Gau JP, et al. Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B. J Clin Oncol 2013;31:2765-2772.
    • (2013) J Clin Oncol , vol.31 , pp. 2765-2772
    • Huang, Y.H.1    Hsiao, L.T.2    Hong, Y.C.3    Chiou, T.J.4    Yu, Y.B.5    Gau, J.P.6
  • 38
    • 52649120886 scopus 로고    scopus 로고
    • Recommendations for identification and public health management of persons with chronic hepatitis B virus infection
    • Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008;57:1-20.
    • (2008) MMWR Recomm Rep , vol.57 , pp. 1-20
    • Weinbaum, C.M.1    Williams, I.2    Mast, E.E.3    Wang, S.A.4    Finelli, L.5    Wasley, A.6
  • 39
    • 84935843497 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
    • Chen KL, Chen J, Rao HL, Guo Y, Huang HQ, Zhang L, et al. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival. Chin J Cancer 2015;34:18.
    • (2015) Chin J Cancer , vol.34 , pp. 18
    • Chen, K.L.1    Chen, J.2    Rao, H.L.3    Guo, Y.4    Huang, H.Q.5    Zhang, L.6
  • 40
    • 84891429810 scopus 로고    scopus 로고
    • Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: a meta-analysis
    • Dong HJ, Ni LN, Sheng GF, Song HL, Xu JZ, Ling Y. Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: a meta-analysis. J Clin Virol 2013;57:209-214.
    • (2013) J Clin Virol , vol.57 , pp. 209-214
    • Dong, H.J.1    Ni, L.N.2    Sheng, G.F.3    Song, H.L.4    Xu, J.Z.5    Ling, Y.6
  • 41
    • 84862771957 scopus 로고    scopus 로고
    • Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy
    • Pei SN, Ma MC, Wang MC, Kuo CY, Rau KM, Su CY, et al. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy. Ann Hematol 2012;91:1007-1012.
    • (2012) Ann Hematol , vol.91 , pp. 1007-1012
    • Pei, S.N.1    Ma, M.C.2    Wang, M.C.3    Kuo, C.Y.4    Rau, K.M.5    Su, C.Y.6
  • 42
    • 84907934932 scopus 로고    scopus 로고
    • Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection
    • Takahata M, Hashino S, Onozawa M, Shigematsu A, Sugita J, Fujimoto K, et al. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection. Transpl Infect Dis 2014;16:797-801.
    • (2014) Transpl Infect Dis , vol.16 , pp. 797-801
    • Takahata, M.1    Hashino, S.2    Onozawa, M.3    Shigematsu, A.4    Sugita, J.5    Fujimoto, K.6
  • 43
    • 53749089012 scopus 로고    scopus 로고
    • HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection
    • Onozawa M, Hashino S, Darmanin S, Okada K, Morita R, Takahata M, et al. HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection. Biol Blood Marrow Transplant 2008;14:1226-1230.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 1226-1230
    • Onozawa, M.1    Hashino, S.2    Darmanin, S.3    Okada, K.4    Morita, R.5    Takahata, M.6
  • 44
    • 84953207576 scopus 로고    scopus 로고
    • Hepatitis B virus reactivation and prophylaxis during solid tumor chemotherapy: a systematic review and meta-analysis
    • Paul S, Saxena A, Terrin N, Viveiros K, Balk EM, Wong JB. Hepatitis B virus reactivation and prophylaxis during solid tumor chemotherapy: a systematic review and meta-analysis. Ann Intern Med 2016;164:30-40.
    • (2016) Ann Intern Med , vol.164 , pp. 30-40
    • Paul, S.1    Saxena, A.2    Terrin, N.3    Viveiros, K.4    Balk, E.M.5    Wong, J.B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.